ESEsen Simsek

Esen Simsek

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Esen Simsek has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Assessing the Prognostic Performance of Pan Immune-Inflammation Value and Inflammatory Biomarkers in Critically Ill Patients with Community-Acquired Pneumonia

    by Murat Daş, Ece Ünal Çetin, Özgür Kurtkulağı, Esen Şimşek, Adil Uğur Çetin, Senem Güler, Yavuz Beyazıt

    Community-acquired pneumonia (CAP) remains a major cause of morbidity and mortality, particularly among critically ill patients in intensive care units (ICUs). Although various clinical scoring systems are used for prognostic stratification, their limitations have prompted interest in novel biomarkers. The pan-immune-inflammation value (PIIV) is a recently proposed index assessing systemic inflammation and immune status. This study investigates the relationship between PIIV, traditional inflammatory markers, and mortality outcomes in ICU-admitted CAP patients. A total of 248 CAP patients were retrospectively analyzed. Demographic, clinical, and laboratory data were obtained from electronic medical records. Associations between these variables and 30-day mortality were evaluated. Univariate and multivariate logistic regression analyses identified independent mortality predictors, and Receiver Operating Characteristic (ROC) analysis assessed diagnostic performance. Among 248 patients, 156 (62.9%) died. PIIV, procalcitonin, lactate, and neutrophil-lymphocyte ratio (NLR) levels were significantly higher in non-survivors. Multivariable analysis identified PIIV (adjusted OR: 1.227; 95% CI: 1.097–1.372; p < 0.001), lactate (adjusted OR: 1.637; 95% CI: 1.290–2.077; p < 0.001), and procalcitonin (adjusted OR: 1.017; 95% CI: 1.002–1.033; p = 0.022), as independent predictors of 30-day mortality. ROC analysis showed optimal cut-off values: PIIV ≥1928.3 (54.5% sensitivity, 70.7% specificity), lactate ≥1.6 mmol/L (75.6% sensitivity), and procalcitonin ≥1.26 ng/mL (73.7% sensitivity, 61.9% specificity). PIIV is an independent prognostic indicator of mortality in CAP patients, reflecting systemic inflammation through multiple hematological parameters. It may capture complex immune-inflammatory dynamics and serve as a useful adjunctive biomarker alongside established markers.

  • Pan-immune-inflammation value and platelet indices as mortality markers in intensive care patients with sepsis

    by Adil Uğur Çetin, Ece Ünal Çetin, Özge Kurtkulağı, Murat Daş, Esen Şimşek, Fatih Kamış, Ferhan Demirer Aydemir, Yavuz Beyazıt

    Objective: Sepsis remains a major global health problem with high morbidity and mortality rates, mostly in intensive care unit (ICU) settings. The Pan-Immune Inflammation Value (PIIV), a composite marker derived from neutrophil, monocyte, platelet, and lymphocyte counts, has recently emerged as a potential indicator of systemic inflammation. This study aimed to evaluate the prognostic performance of PIIV and platelet-derived indices, including mean platelet volume (MPV) in predicting 30-day mortality among ICU-admitted sepsis patients.Methods: This retrospective study included 191 adult patients with sepsis admitted to the ICU of a tertiary care hospi-tal. Laboratory parameters, including PIIV, MPV, PLR, and lactate, along with various clinical and laboratory parame-ters were recorded within the first 24 hours of ICU admission. Logistic regression analysis (LRA) and receiver operat-ing characteristic curve (ROC) analysis were performed to determine predictors of 30-day mortality.Results: Of the total cohort, 96 patients (50.3%) died within 30 days after ICU admission. PIIV, MPV, and lactate levels were found to be elevated in non-survivors (p=0.001, p=0.003, and p=0.001, respectively). In multivariate LRA, PIIV (OR: 1.235; 95% CI: 1.086–1.404; p=0.001), MPV (OR: 1.346; 95% CI: 1.111–1.630; p=0.002), lactate, and urea were independently associated with mortality. ROC analysis showed that PIIV had an AUROC of 0.643 at a cut-off value of ≥1.2, while MPV had an AUROC of 0.623 at a cut-off of ≥11.5 fL.Conclusion: Integrating PIIV and MPV into the clinical assessment of sepsis patients may improve decision-making in the management of critically ill septic patients in intensive care units.


  • Open Access

    Lactate–albumin ratio improves combined predictive value of qSOFA and MEWS for 30-day mortality in ICU patients with sepsis: A retrospective cohort study

    by Ece Unal Cetin, Ozge Kurtkulagi, Fatih Kamis, Murat Das, Esen Simsek, Adil Ugur Cetin, Ferhan Demirer Aydemir, Yavuz Beyazit

    Evaluating disease severity and predicting adverse outcomes using various risk prediction tools in early disease stages is essential to reduce sepsis-related mortality. Unfortunately, there is still no clear consensus on the best score. The present study aimed to develop and validate a multivariable risk prediction model for 30-days mortality by combining the lactate-to-albumin (L/A) ratio, Modified Early Warning Score (MEWS), and quick Sequential Organ Failure Assessment (qSOFA) in sepsis patients admitted to the intensive care unit (ICU). This retrospective study included ICU patients with suspected sepsis. We computed L/A ratio, MEWS, and qSOFA within 24 hours of ICU admission. Patients were followed until either death/hospital discharge or 30 days, whichever came first. The predictive performance of each scoring system and their combinations was assessed using logistic regression and receiver operating characteristic curve analyses. A total of 130 patients with sepsis admitted to the ICU were included in the study. The mortality rate was 63.07% (82/130). A higher L/A ratio, MEWS, and qSOFA were found to be associated with mortality in ICU sepsis patients. A statistically significant difference in terms of predicting mortality was demonstrated in the pairwise comparison after combining the L/A ratio with both the qSOFA and MEWS (difference between areas: −0.098, P = .011 and difference between areas: −0.098, P = .013 respectively). Mortality models combining L/A ratio with selected clinical variables have improved mortality prediction performance compared with models that use MEWS and qSOFA alone. The L/A ratio at ICU admission provide valuable prognostic information for predicting 30-days mortality in sepsis patients. Combining these ratio with MEWS and qSOFA improves the accuracy of predicting mortality in patients with sepsis.


  • Open Access

    Development of a novel clinical prediction model for sepsis related mortality by combining NEWS, PIRO and lactate

    by Ozge Kurtkulagi, Ece Unal Cetin, Fatih Kamis, Murat Das, Esen Simsek, Ozgur Kurtkulagi, Adil Ugur Cetin, Yavuz Beyazit

    Prognostic assessment plays a crucial role in guiding therapeutic decision-making for patients with sepsis, particularly in intensive care settings. This study aimed to develop a multivariable model to predict 28-day mortality among intensive care unit (ICU) patients with sepsis by integrating serum lactate levels, the National Early Warning Score (NEWS), and the Predisposition, Infection, Response, and Organ Dysfunction (PIRO) score. Demographic information, clinical characteristics, and laboratory findings routinely collected at ICU admission were used to calculate the NEWS and PIRO scores for each patient. Patients were categorized as survivors or non-survivors based on their outcome. Both logistic regression and Cox proportional hazards models were applied for mortality prediction analysis. The final analysis included 205 patients diagnosed with sepsis (mean age: 73.6 ± 13.2 years; 53.2% male), of whom 109 died during hospitalization. Logistic regression analysis revealed that lactate, NEWS, and PIRO scores were independently associated with 28-day mortality. Combining lactate levels with NEWS and PIRO significantly enhanced mortality prediction, with the greatest accuracy observed when all three parameters were integrated. Pairwise analyses demonstrated that adding lactate to the base model significantly improved predictive accuracy (DBA: −0.103, p = 0.003), and incorporating lactate into a model already including NEWS further enhanced its predictive value (DBA: −0.042, p = 0.037). In conclusion, serum lactate measured at initial ICU admission provides valuable prognostic information for predicting 28-day mortality in sepsis patients. Furthermore, combining lactate levels with NEWS and PIRO scores substantially enhances the accuracy of mortality prediction in these patients.


  • Open Access

    Advancing ICU mortality prediction in community-acquired pneumonia: Combining fibrinogen-to-albumin ratio, CT severity score, PSI, and CURB-65

    by Ece Unal Cetin, Ozge Kurtkulagi, Fatih Kamis, Murat Das, Esen Simsek, Adil Ugur Cetin, Yavuz Beyazit

    Community-acquired pneumonia (CAP) is a leading cause of ICU admissions, with significant morbidity and mortality. Traditional risk stratification tools, such as CURB-65, the pneumonia severity index (PSI), and computed tomography severity scores (CT-SS) are widely used for prognosis but could be improved by incorporating novel biomarkers. This retrospective study evaluated the fibrinogen-to-albumin ratio (FAR) as an additional predictor of 30-day mortality in ICU patients with CAP. A total of 158 CAP patients admitted to a tertiary care ICU were included. Baseline data encompassed demographic, clinical, laboratory, and radiological parameters, including FAR, CURB-65, PSI, and CT-SS. Logistic regression and receiver operating characteristic curve (ROC) analyses were conducted to assess mortality predictors. The 30-day mortality rate was 70.88% (112/158). Higher FAR, PSI, CURB-65, CT-SS, and lactate levels were independently associated with increased mortality (P < 0.05). FAR demonstrated strong discriminatory power (area under the receiver operating characteristic [AUROC]: 0.704) and significantly improved the predictive accuracy of established models. Adding FAR to PSI increased the AUROC from 0.705 to 0.791 (P = 0.009), while combining FAR, CT-SS, and PSI yielded the highest predictive accuracy (AUROC: 0.844, P = 0.032). These findings suggest that FAR, which reflects both inflammation and nutritional status, complements traditional risk assessment tools by providing a dynamic perspective. Integrating FAR into existing models enhances the identification of high-risk patients, enabling timely interventions and more efficient resource allocation in the ICU.